The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Open accessAbstract
As the concentrations of highly consumed nutrients, particularly glucose, are generally lower in tumours than in normal tissues, cancer cells must adapt their metabolism to the tumour microenvironment. A better understanding of these adaptations might reveal cancer cell liabilities that can be exploited for therapeutic benefit. Here we developed a continuous-flow culture apparatus (Nutrostat) for maintaining proliferating cells in low-nutrient media for long periods of time, and used it to undertake competitive proliferation assays on a pooled collection of barcoded cancer cell lines cultured in low-glucose conditions. Sensitivity to low glucose varies amongst cell lines, and an RNA interference (RNAi) screen pinpointed mitochondrial oxidative phosphorylation (OXPHOS) as the major pathway required for optimal proliferation in low glucose. We found that cell lines most sensitive to low glucose are defective in the OXPHOS upregulation that is normally caused by glucose limitation as a result of either mitochondrial DNA (mtDNA) mutations in complex I genes or impaired glucose utilization. These defects predict sensitivity to biguanides, antidiabetic drugs that inhibit OXPHOS, when cancer cells are grown in low glucose or as tumour xenografts. Notably, the biguanide sensitivity of cancer cells with mtDNA mutations was reversed by ectopic expression of yeast NDI1, a ubiquinone oxidoreductase that allows bypass of complex I function. Thus, we conclude that mtDNA mutations and impaired glucose utilization are potential biomarkers for identifying tumours with increased sensitivity to OXPHOS inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings confirm previous studies that analyzed inhibition of either glycolysis or OXPHOS, and observed an increase in the activity of the other pathway (Hao et al., 2010; Jose et al., 2011; Birsoy et al., 2014; Dykens et al., 2008).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Birsoy et al., 2014
In the citing paper
“Cancer cells with reduced OXPHOS due to either mutated mitochondrial DNA or impaired glucose utilization were unable to initiate this adaptive response, and were thus particularly sensitive to glucose deprivation to one-tenth of normal levels (Birsoy et al., 2014).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Birsoy et al., 2014
In the citing paper
“These results are consistent with previous studies reporting the synergism of the metformin/low glucose combination (Birsoy et al., 2014; Zhuang et al., 2014).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Birsoy et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Self-citationMetabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
Self-citationEl-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshitá, T., Saito, N., Ochiai, A., Tomita, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4806 · Cited by 965
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918
Observations on the carbohydrate metabolism of tumours
Crabtree, H. G. (1929) · Biochemical Journal · doi:10.1042/bj0230536 · Cited by 864
Cited by
Sorted by citations
Items 201–300 of 710
Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
Curry, J., Johnson, J. M., Tassone, P. T., Domingo‐Vidal, M., Menezes, D. W., Sprandio, J. D., Mollaee, M., Cotzia, P., Birbe, R., Lin, Z., et al. (2017) · The Laryngoscope · doi:10.1002/lary.26489 · Cited by 72
Dykes, S. S., Gray, A. L., Coleman, D. T., Saxena, M., Stephens, C. A., Carroll, J. L., Pruitt, K., & Cardelli, J. A. (2016) · Oncotarget · doi:10.18632/oncotarget.8832 · Cited by 69
Glick, G. D., Rossignol, R., Lyssiotis, C. A., Wahl, D. R., Lesch, C. A., Sanchez, B., Liu, X., Hao, L.-Y., Taylor, C. B., Hurd, A. R., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218099 · Cited by 70
Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer
Wang, Q., Li, M., Gan, Y., Jiang, S., Qiao, J., Zhang, W., Fan, Y., Shen, Y., Song, Y., Meng, Z., et al. (2020) · Theranostics · doi:10.7150/thno.38704 · Cited by 69
Cheng, C.-T., Kuo, C., Ouyang, C., Li, C., Chung, Y., Chan, D. C., Kung, H.-J., & Ann, D. K. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2921 · Cited by 66
Determinants of nutrient limitation in cancer
Sullivan, M. R., & Heiden, M. G. V. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1611733 · Cited by 70
Therapeutic Repurposing of Biguanides in Cancer
Zhao, H., Swanson, K. D., & Zheng, B. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.03.001 · Cited by 69
Use of metformin and survival of patients with high‐grade glioma
Seliger, C., Luber, C. A., Gerken, M., Schaertl, J., Proescholdt, M. A., Riemenschneider, M. J., Meier, C. R., Bogdahn, U., Leitzmann, M. F., Klinkhammer‐Schalke, M., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31783 · Cited by 66
Xiao, Y., Chen, P., Lei, S., Bai, F., Fu, L., Lin, J., & Huang, P. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202204584 · Cited by 67
Pachnis, P., Wu, Z., Faubert, B., Tasdogan, A., Gu, W., Shelton, S. D., Solmonson, A., Rao, A. D., Kaushik, A., Rogers, T. J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn9550 · Cited by 65
Metabolic synthetic lethality in cancer therapy
Zecchini, V. R., & Frezza, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.12.003 · Cited by 63
Zhang, B., Chu, W. H., Wei, P., Liu, Y., & Wei, T. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.09.021 · Cited by 63
Rozengurt, E. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00357 · Cited by 67
Tsao, C., & Yang, Z.-J. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b07395 · Cited by 63
Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth
Lakhter, A. J., Hamilton, J., Konger, R. L., Brustovetsky, N., Broxmeyer, H. E., & Naidu, S. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712166 · Cited by 71
Recent advances in cancer metabolism: a technological perspective
Kang, Y. P., Ward, N. P., & DeNicola, G. M. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0027-z · Cited by 65
Druck, T., Cheung, D. G., Park, D., Trapasso, F., Pichiorri, F., Gaspari, M., Palumbo, T., Aqeilan, R. I., Gaudio, E., Okumura, H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1414-7 · Cited by 65
Swiercz, R., Mo, M., Khare, P., Schneider, Z., Ober, R. J., & Ward, E. S. (2016) · Oncotarget · doi:10.18632/oncotarget.13869 · Cited by 64
Hennequart, M., Labuschagne, C. F., Tajan, M., Pilley, S. E., Cheung, E. C., Legrave, N. M., Driscoll, P. C., & Vousden, K. H. (2021) · Nature Communications · doi:10.1038/s41467-021-26395-5 · Cited by 62
Bizjak, M., Malavašič, P., Dolinar, K., Pohar, J., Pirkmajer, S., & Pavlin, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01801-5 · Cited by 66
Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis
Seliger, C., Genbrugge, E., Gorlia, T., Chinot, O. L., Stupp, R., Nabors, B., Weller, M., Hau, P., & for the EORTC Brain Tumor Group (2019) · International Journal of Cancer · doi:10.1002/ijc.32337 · Cited by 61
Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinoma
Capece, D., D’Andrea, D., Begalli, F., Goracci, L., Tornatore, L., Alexander, J. L., Veroli, A. D., Leow, S. C., Vaiyapuri, T. S., Ellis, J. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci137845 · Cited by 60
A hydride transfer complex reprograms NAD metabolism and bypasses senescence
Igelmann, S., Lessard, F., Uchenunu, O., Bouchard, J., Fernandez-Ruiz, A., Rowell, M.-C., Lopes-Paciencia, S., Papadopoli, D., Fouillen, A., Ponce, K. J., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.028 · Cited by 60
Jü, R., Guo, L., Li, J., Zhu, L., Yu, X., Chen, C., Chen, W., Ye, C., & Zhang, D. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.025 · Cited by 65
Self-citationAberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer
Zhang, B., Wang, J., Huang, Z. J., Wei, P., Liu, Y., Hao, J., Zhao, L., Zhang, F., Tu, Y., & Wei, T. (2015) · Oncotarget · doi:10.18632/oncotarget.6252 · Cited by 59
Targeted Tumor Therapy Remixed—An Update on the Use of Small-Molecule Drugs in Combination Therapies
Gatzka, M. (2018) · Cancers · doi:10.3390/cancers10060155 · Cited by 57
Glucose-deprivation increases thyroid cancer cells sensitivity to metformin
Bikas, A., Jensen, K. E., Patel, A. D., Costello, J. M., McDaniel, D. P., Kłubo-Gwieździńska, J., Ларін, О. С., Hoperia, V., Burman, K. D., Boyle, L., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0402 · Cited by 63
He, K., Guo, X., Liu, Y., Li, J., Hu, Y., Wang, D., & Song, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2122-9 · Cited by 60
Jung, K.-A., Lee, S., & Kwak, M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6797 · Cited by 60
Jankú, F., Beom, S., Moon, Y. W., Kim, T. W., Shin, Y. G., Yim, D., Kim, G. M., Kim, H. S., Kim, S. Y., Cheong, J., et al. (2022) · Investigational New Drugs · doi:10.1007/s10637-022-01277-9 · Cited by 58
Catabolic metabolism during cancer EMT
Cha, Y. H., Yook, J. I., Kim, H. S., & Kim, N. H. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0567-x · Cited by 59
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
Cuyàs, E., Fernández‐Arroyo, S., Corominas-Faja, B., Rodríguez‐Gallego, E., Bosch‐Barrera, J., Martı́n-Castillo, B., Llorens, R., Joven, J., & Menéndez, J. A. (2015) · Oncotarget · doi:10.18632/oncotarget.3733 · Cited by 60
Liu, J., Li, J., Chen, H., Wang, R., Li, P., Miao, Y., & Liu, P. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15241 · Cited by 59
Lagziel, S., Gottlieb, E., & Shlomi, T. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00299-y · Cited by 58
Birts, C. N., Banerjee, A., Darley, M., Dunlop, C. R., Nelson, S., Nijjar, S. K., Parker, R., West, J. J., Tavassoli, A., Rose-Zerilli, M. J. J., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aau9529 · Cited by 56
Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy
Chen, C., Wang, Z., & Qin, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.935536 · Cited by 62
Insights into the New Cancer Therapy through Redox Homeostasis and Metabolic Shifts
Hyun, D. (2020) · Cancers · doi:10.3390/cancers12071822 · Cited by 58
Sviderskiy, V. O., Blumenberg, L., Gorodetsky, E., Karakousi, T. R., Hirsh, N., Alvarez, S. W., Terzi, E. M., Kaparos, E., Whiten, G. C., Ssebyala, S., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.016 · Cited by 56
Self-citationMetabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells
Yu, H. J., Zhang, H., Dong, M., Zhou, W., Shen, Z., Xie, Y., Kong, Z., Dai, X., & Xu, B. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3794 · Cited by 55
Deng, Z., Li, X., Ramírez, M. B., Purtell, K., Choi, I., Lu, J., Yu, Q., & Yue, Z. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020215118 · Cited by 52
Metformin, an Old Drug, Brings a New Era to Cancer Therapy
He, H., Ke, R., Lin, H., Ying, Y., Liu, D., & Luo, Z. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000103 · Cited by 55
Guevara‐Aguirre, J., & Rosenbloom, A. L. (2014) · Diabetologia · doi:10.1007/s00125-014-3397-3 · Cited by 55
Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells
Relation, T., Dominici, M., & Horwitz, E. M. (2017) · Stem Cells · doi:10.1002/stem.2596 · Cited by 55
Almutairi, F. M., Abdrabou, A., & Mohamed, M. S. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.03.004 · Cited by 55
The requirement of mitochondrial RNA polymerase for non-small cell lung cancer cell growth
Zhou, T., Sang, Y., Cai, S., Xu, C., & Shi, M.-H. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04039-2 · Cited by 53
PCK2 opposes mitochondrial respiration and maintains the redox balance in starved lung cancer cells
Bluemel, G., Planque, M., Madreiter‐Sokolowski, C. T., Haitzmann, T., Hrzenjak, A., Graier, W. F., Fendt, S., Olschewski, H., & Leithner, K. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.007 · Cited by 54
Liang, Y., Ye, F., Luo, D., Long, L., Wang, Y., Jin, Y., Wang, L., Li, Y., Han, D., Chen, B., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02037-4 · Cited by 54
Mastering the use of cellular barcoding to explore cancer heterogeneity
Serrano, A., Berthelet, J., Naik, S. H., & Mérino, D. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00500-2 · Cited by 53
Takizawa, I., Lawrence, M. G., Balanathan, P., Rebello, R. J., Pearson, H. B., Garg, E., Pedersen, J., Pouliot, N., Nadon, R., Watt, M. J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2820 · Cited by 54
Talarico, G., Orecchioni, S., Dallaglio, K., Reggiani, F., Mancuso, P., Calleri, A., Gregato, G., Labanca, V., Rossi, T., Noonan, D. M., et al. (2016) · Scientific Reports · doi:10.1038/srep18673 · Cited by 53
Huang, C., Li, Y., Li, Z., Xu, Y., Li, N., Ge, Y., Dong, J., Chang, A., Zhao, T., Wang, X., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3533 · Cited by 53
Magno, L. D., Manni, S., Pastena, F. D., Coni, S., Macone, A., Cairoli, S., Sambucci, M., Infante, P., Moretti, M., Petroni, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.024 · Cited by 56
Metabolic determinants of cellular fitness dependent on mitochondrial reactive oxygen species
Kong, H., Reczek, C. R., McElroy, G. S., Steinert, E. M., Wang, T., Sabatini, D. M., & Chandel, N. S. (2020) · Science Advances · doi:10.1126/sciadv.abb7272 · Cited by 56
Self-citationMeijer, T. W. H., Peeters, W. J. M., Dubois, L. J., van Gisbergen, M. W., Biemans, R., Venhuizen, J., Span, P. N., & Bussink, J. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.10.016 · Cited by 52
Physiological Media in Studies of Cell Metabolism
Golikov, M. V., Треворович, В.-Э. В., Smirnova, O. A., & Ivanov, A. V. (2022) · Molecular Biology · doi:10.1134/s0026893322050077 · Cited by 51
Mitofusin-2 Regulates Platelet Mitochondria and Function
Jacob, S. P., Kosaka, Y., Bhatlekar, S., Denorme, F., Benzon, H., Moody, A., Moody, V., Tugolukova, E. A., Hull, G., Kishimoto, N. Y., et al. (2023) · Circulation Research · doi:10.1161/circresaha.123.322914 · Cited by 51
Acidosis orchestrates adaptations of energy metabolism in tumors
Groessl, S., Kalis, R., Snaebjornsson, M. T., Wambach, L., Haider, J., Andersch, F., Schulze, A., Palm, W., & Zuber, J. A. (2025) · Science · doi:10.1126/science.adp7603 · Cited by 58
Targeting Cell Metabolism as Cancer Therapy
Ngoi, N. Y. L., Eu, J. Q., Hirpara, J. L., Wang, L., Lim, J. S. J., Lee, S. C., Lim, Y., Pervaiz, S., Goh, B. C., & Wong, A. L. A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7947 · Cited by 52
NFAT5 promotes oral squamous cell carcinoma progression in a hyperosmotic environment
Yoshimoto, S., Morita, H., Matsuda, M., Katakura, Y., Hirata, M., & Hashimoto, S. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00486-1 · Cited by 50
Regulation of organelle function by metformin
Kim, J., & You, Y. (2017) · IUBMB Life · doi:10.1002/iub.1633 · Cited by 50
Lord, S., Collins, J. M., Cheng, W., Haider, S. A., Wigfield, S., Gaude, E., Fielding, B. A., Pinnick, K. E., Harjes, U., Segaran, A., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0665-5 · Cited by 49
Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex I
Jain, S., Hu, C., Kluza, J., Ke, W., Tian, G., Giurgiu, M., Bleilevens, A., Campos, A. R., Charbono, A., Stickeler, E., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.11.002 · Cited by 48
Parzych, K., Saavedra-García, P., Valbuena, G. N., Al-Sadah, H. A., Robinson, M. E., Penfold, L., Kuzeva, D. M., Ruiz-Tellez, A., Loaiza, S., Holzmann, V., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0651-z · Cited by 51
p21cip1/waf1 Coordinates Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress
Manu, K. A., Cao, P. H. A., Chai, T. F., Casey, P. J., & Wang, M. (2019) · Cancers · doi:10.3390/cancers11081112 · Cited by 47
Qi, J., Zhou, N., Li, L., Mo, S., Zhou, Y., Deng, Y. J., Chen, T., Shan, C., Chen, Q., & Lü, B. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02779-1 · Cited by 50
Huang, J., Zhao, L., Zhou, X., Liu, L., Zheng, R., Deng, F., Liu, Y., Yu, X., Li, S., & Cheng, H. B. (2022) · Small · doi:10.1002/smll.202107467 · Cited by 48
Helenius, I. T., Madala, H. R., & Yeh, J.-R. J. (2021) · Biomolecules · doi:10.3390/biom11111666 · Cited by 43
Ledderose, C., Woehrle, T., Ledderose, S., Strasser, K., Seist, R., Bao, Y., Zhang, J., & JUNGER, W. G. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9510-y · Cited by 50
Valaee, S., Yaghoobi, M. M., & Shamsara, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174486 · Cited by 49
Self-Assembled Multiple-Enzyme Composites for Enhanced Synergistic Cancer Starving–Catalytic Therapy
Wang, H., Cheng, L., Ma, S., Ding, L., Zhang, W., Xu, Z., Li, D., & Gao, L. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c02006 · Cited by 47
Cancer cell metabolism connects epigenetic modifications to transcriptional regulation
Morrison, A. J. (2021) · FEBS Journal · doi:10.1111/febs.16032 · Cited by 47
Germline SDHA mutations in children and adults with cancerPreprint
Dubard-Gault, M. E., Mandelker, D. L., DeLair, D. F., Stewart, C., Kemel, Y. M., Sheehan, M. R., Siegel, B., Kennedy, J. A., Marcell, V. J., Arnold, A. G., et al. (2018) · Molecular Case Studies · doi:10.1101/mcs.a002584 · Cited by 50
Self-citationLiu, F., Kalpage, H. A., Wang, D., Edwards, H. J., Hüttemann, M., Ma, J., Su, Y., Carter, J. L., Li, X., Polin, L., et al. (2020) · Cancers · doi:10.3390/cancers12092400 · Cited by 46
Organization of Enzyme Concentration across the Metabolic Network in Cancer Cells
Madhukar, N. S., Warmoes, M. O., & Locasale, J. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117131 · Cited by 45
Flexibility and Adaptation of Cancer Cells in a Heterogenous Metabolic Microenvironment
Bluemel, G., Mondal, A., & Leithner, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031476 · Cited by 44
Golikov, M. V., Karpenko, I. L., Lipatova, A. V., Ivanova, O. N., Тимофеевна, Ф. И., Филиппович, Л. В., Zakirova, N. F., Leonova, O. G., Попенко, В. И., Bartosch, B., et al. (2021) · Antioxidants · doi:10.3390/antiox11010097 · Cited by 45
Yang, S., Huang, Y., & Zhao, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878740 · Cited by 50
Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy
Kumar, R., Mishra, A., Gautam, P., Feroz, Z., Vijayaraghavalu, S., Likos, E., Shukla, G. C., & Kumar, M. (2022) · Cancers · doi:10.3390/cancers14215268 · Cited by 50
Mitochondria-targeted metformins: anti-tumour and redox signalling mechanisms
Kalyanaraman, B., Cheng, G., Hardy, M., Ouari, O., Sikora, A., Zielonka, J., & Dwinell, M. B. (2017) · Interface Focus · doi:10.1098/rsfs.2016.0109 · Cited by 44
Duan, H., Ren, J., Wei, S., Yang, Z., Li, C., Wang, Z., Li, M., Wei, Z., Liu, Y., Wang, X., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01410-8 · Cited by 47
AG311, a small molecule inhibitor of complex I and hypoxia-induced HIF-1α stabilization
Bastian, A., Matsuzaki, S., Humphries, K. M., Pharaoh, G. A., Doshi, A., Zaware, N., Gangjee, A., & Ihnat, M. A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.040 · Cited by 43
Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2
Jiang, S., Dong, F.-Y., Da, L., Yang, X., Wang, X., Weng, J.-Y., Feng, L., Zhu, L., Zhang, Y., Zhang, Z., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201901237r · Cited by 43
Ulmer, C. Z. (2015) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000360 · Cited by 41
Role of coenzymes in cancer metabolism
Thapa, M., & Dallmann, G. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.027 · Cited by 45
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer
Litchfield, L. M., Mukherjee, A., Eckert, M. A., Johnson, A., Mills, K. A., Pan, S., Shridhar, V., Lengyel, E. R., & Romero, I. L. (2015) · Oncotarget · doi:10.18632/oncotarget.4556 · Cited by 44
Farris, J. C., Pifer, P. M., Zheng, L., Gottlieb, E., Denvir, J., & Frisch, S. M. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0050 · Cited by 43
UPF1 inhibits the hepatocellular carcinoma progression by targeting long non-coding RNA UCA1
Zhou, Y., Li, Y., Wang, N., Li, X., Zheng, J., & Ge, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-43148-z · Cited by 41
Nanomedicines Targeting Glioma Stem Cells
Sabu, A., Liu, T., Ng, S. S., Doong, R., Huang, Y., & Chiu, H. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c03538 · Cited by 46
Senkowski, W., Jarvius, M., Rubin, J., Lengqvist, J., Gustafsson, M. G., Nygren, P., Kultima, K., Larsson, R. L., & Fryknäs, M. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.09.013 · Cited by 41
Yi, Y., Chen, D., Ao, J., Sun, S., Wu, M. C., Li, X., Bergholz, J. S., Zhang, Y., & Xiao, Z. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.769141 · Cited by 40
Wang, Y., Zhang, S., Xu, T., Zhang, T., Mo, Y., Liu, J., Yan, L.-Q., & Xing, F. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.02.095 · Cited by 40
Metabolic Rewiring in Response to Biguanides Is Mediated by mROS/HIF-1a in Malignant Lymphocytes
Khan, H., Anshu, A., Prasad, A. K., Roy, S., Jeffery, J. J., Kittipongdaja, W., Yang, D. T., & Schieke, S. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.007 · Cited by 42
Yi, Y., Wang, G., Zhang, W., Yu, S., Fei, J., An, T., Yi, J., Li, F., Huang, T., Yang, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55768-9 · Cited by 45
Joly, J. H., Lowry, W. E., & Graham, N. A. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa658 · Cited by 41
Energy sources identify metabolic phenotypes in pancreatic cancer
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw097 · Cited by 37
The biological role of metabolic reprogramming in pancreatic cancer
Suzuki, T., Otsuka, M., Seimiya, T., Iwata, T., Kishikawa, T., & Koike, K. (2020) · MedComm · doi:10.1002/mco2.37 · Cited by 38
Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes
Han, K. C.-Z., Pintilie, M., Lipscombe, L. L., Lega, I. C., Milosevic, M., & Fyles, A. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1008 · Cited by 37
Qian, R., Lv, J. C., & Long, Y. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04159 · Cited by 38
Zhang, H., Zhu, K., Zhang, R., Guo, Y., Wang, J., Liu, C., Lu, X., Zhou, Z., Wu, W., Zhang, F., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000784 · Cited by 37
Zhang, L., Ma, J., Yang, B., Zhao, J., Yan, B., Zhang, Y., & Li, W. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0958-2 · Cited by 37
Metadata
- Authors
- Birsoy, K., Possemato, R., Lorbeer, F. K., Bayraktar, E. C., Thiru, P., Yucel, B., Wang, T., Chen, W. W., Clish, C. B., & Sabatini, D. M.
- Affiliations
- Broad Institute (US)
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Sabatini, David M.
- ORCID
- Venue
- Nature
- Published
- 2014-03-16
- Volume
- 508
- Issue
- 7494
- Pages
- 108-112
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4012432
- OpenAlex
- W2104696999
- Cited by
- 710
- References
- 27
- Citations by year
- 2026: 17 · 2025: 44 · 2024: 58 · 2023: 46 · 2022: 60 · 2021: 75 · 2020: 83 · 2019: 71 · 2018: 51 · 2017: 49 · 2016: 61 · 2015: 59 · 2014: 35
- FWCI
- 21.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (CA129105, K99CA168940, CA103866, R01CA103866, R01CA129105, R00CA168940)
- National Institute of General Medical Sciences (T32GM007287)
- National Institute of Allergy and Infectious Diseases (AI-07389, T32AI007389)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- glucose limitation, biguanides, mitochondrial oxidative phosphorylation, cancer metabolism, mitochondrial DNA mutations, complex I, antidiabetic drugs, OXPHOS inhibitors, continuous flow culture, tumor microenvironment, NDI1, glucose utilization, cancer cell lines, drug sensitivity biomarkers
- MeSH terms
- Adenosine Triphosphate, Animals, Biguanides, Culture Media, DNA, Mitochondrial, Glucose, Humans, Hypoglycemic Agents, Male, Mitochondria, Mutation, Neoplasm Transplantation, Neoplasms, Oxidative Phosphorylation, Phenformin, Cell Culture Techniques, Xenograft Model Antitumor Assays, Saccharomyces cerevisiae Proteins, RNA Interference, Electron Transport Complex I, Cell Line, Tumor, Cell Proliferation, Mice, Molecular Typing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
